Skip to main content
logo
Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
0.6800
+0.0030 (0.44%)
Aug 6, 2026, 10:35 AM EDT - Market open

Inovio Pharmaceuticals Revenue

In the year 2025, Inovio Pharmaceuticals had annual revenue of $65.34K, down -69.99%.

Revenue (ttm)
$65.34K
Revenue Growth
-69.99%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
112
Market Cap
74.56M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202565.34K-152.41K-69.99%
Dec 31, 2024217.76K-614.25K-73.83%
Dec 31, 2023832.01K-9.43M-91.89%
Dec 31, 202210.26M8.49M478.23%
Dec 31, 20211.77M-5.64M-76.05%
Dec 31, 20207.41M--
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---
Dec 31, 2007---
Dec 31, 2006---
Dec 31, 2005---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Xilio Therapeutics53.48M
Immutep5.28M
Seres Therapeutics1.15M
Mereo BioPharma Group500.00K
aTyr Pharma190.00K
INmune Bio50.00K
Revenue Rankings

INO News

More News